| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $76.40K | $95.79K | $64.83K | $3.18M | $14.71K |
| R&D | – | – | – | – | – |
| SG&A | $53.03K | $35.17K | $64.83K | $33.72K | $14.71K |
| Operating Income | -$76.40K | -$95.79K | -$64.83K | -$3.18M | -$14.71K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$76.40K | -$95.79K | -$64.83K | -$3.18M | -$14.71K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Shares (diluted) | $1.05B | $1.02B | $876.09M | $723.95M | $396.09M |